News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
247 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Pharm Country
Celgene Prices $3 Billion of Senior Unsecured Notes
Of these notes, $750 million will mature in 2023 and will bear interest at an annual rate of 2.750 percent.
November 1, 2017
·
4 min read
Business
bluebird bio Reports Third Quarter 2017 Financial Results and Recent Operational Progress
bluebird bio reported business highlights and financial results for the third quarter ended September 30, 2017.
November 1, 2017
·
13 min read
Business
Heska Announces 7-Year Agreement with PetVetCare Centers
Heska announced today an agreement to supply over 100 PetVetCare veterinary hospitals with in-house laboratory diagnostic equipment and supplies through 2024, which may be extended by the Parties.
November 1, 2017
·
4 min read
Policy
Leading Generics Pharmaceutical Company, Normon Laboratories, Selects TraceLink to Comply with EU FMD Serialization Regulations
TraceLink today announced that Normon Laboratories, has selected TraceLink’s serialization solutions to comply with the EU Falsified Medicines Directive (FMD) serialization requirements.
November 1, 2017
·
4 min read
Business
Intrexon to Announce Third Quarter 2017 Financial Results on November 9th
The Company will host a conference call that day at 5:30 PM ET to discuss the results and provide a general business update.
November 1, 2017
·
2 min read
Business
Genomic Health to Announce Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017
The call and webcast will follow the release of the third quarter financial results after market close.
November 1, 2017
·
2 min read
Business
Medizone International Concludes Exclusive Product Supply and License Agreement With Innovasource
Pursuant to the Supply Agreement, Innovasource will supply its custom-formulated, EPA-registered hydrogen peroxide based disinfectant product to Medizone for use in the AsepticSure Disinfection System.
November 1, 2017
·
4 min read
Biotech Bay
Global Availability of Varian Halcyon Treatments Expands with First Cancer Patient Treated in Australia
Varian Medical Systems announced a 71-year-old male with prostate cancer became the first patient in Australia to be treated on the Halcyon system at ROC in Toowoomba by Brisbane-based Icon Group.
November 1, 2017
·
2 min read
Business
Purdue Pharma Joins the Prescription Drug Safety Network
The course includes interactive sessions and self-guided activities to empower students with knowledge, skills, and strategies to help prevent prescription drug misuse and abuse.
November 1, 2017
·
4 min read
Business
ImmusanT Blood Test Differentiates Celiac From Non-Celiac Patients Through Cytokine Levels
ImmusanT today announced data from its collaboration with Norwegian researchers demonstrating an ability to differentiate celiac disease and non-celiac gluten-sensitive patients based on cytokine levels.
November 1, 2017
·
5 min read
Previous
4 of 25
Next